DreamPharm Products:
Lutein-20||Herbs for headache, fever, and migraine ||
Milk thistle||Saw palmetto||
Triple B Super Vision||Garlic, Ginger, and Grapeseed Extract||
Ginseng and Ginkgo||Hair Million||
DHEA||Coenzyme Q10||
Sleep Aid herbal formula - natural sleep aid||Herbal Breath - herbs for bad breath problems.||
Weight loss herbal formula for menopause and pms||Ginkgo biloba||
Colon cleansing, Laxative||ViaVita, Lecithin for healthy liver
Fatty acids resources:
Pathogen research abs 1 || Pathogen research abs 2 || Pathogen research abs 3 || Pathogen research abs 4 || Pathogen research abs 5 ||
Hormone and endocrine research abs 1 || Hormone and endocrine research abs 2 || Hormone and endocrine research abs 3 || Hormone and endocrine research abs 4 || Hormone and endocrine research abs 5
|| Follicle and follicular cells research abs 1
|| Interferon research abs 1
|| Hemoglobin research abs
|| Stem cell research abs
|| Nucleic acid research abs
|| Herpes research abs
|| Bronchitis research abs
Mol Cell Probes. 1999 Feb;13(1):1-7.
A multiplex PCR for Massachusetts and Arkansas serotypes of infectious bronchitis virus.
Wang X, Khan MI.
Department of Pathobiology, University of Connecticut, U-89,61 North Eagleville Road, Storrs, CT, 06269-3089, USA.
Infectious bronchitis virus (IBV), the prototype of the coronavirus family, is an enveloped, single-stranded RNA virus with a genome size of approximately 27.6 kilobase. Infectious bronchitis virus causes an acute, highly contagious respiratory and urogenital disease of chickens which results in significant economic losses in commercial broilers, layers and breeders. A rapid, highly sensitive and specific method is needed in the differential diagnosis of infections of different serotypes. A multiplex polymerase chain reaction (PCR) method was developed and optimized to simultaneously detect Massachusetts (Mass) and Arkansas (Ark) serotypes of IBV. One common primer and two serotype specific primers were chosen from the S1 gene sequences of IBV and used in one PCR reaction. Under optimized PCR conditions, two serotype specific PCR products, 1026 bp for Mass and 896 bp for Ark, respectively, were amplified and detected by agarose gel electrophoreses. The specificity of the technique was verified by using 20 different strains and isolates of IBV, and other avian bacterial and viral pathogens. Using a serial 10-fold dilution of the artificial mixture of both Mass and Ark samples, the detection limit was found to be 5 pg RNA after 35 cycles of PCR. The multiplex PCR was able to detect and differentiate both serotypes in embryonated eggs that were co-infected with different EID50virus titers of Mass 41 and Ark 99. The multiplex PCR developed in this study will be valuable for rapid identification, differential diagnosis, and epidemiological studies of these two serotypes of IBV infections. 1999 Academic Press.
online pharmacy ref. source: www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10024427&dopt=Abstract
Thorax. 2003 Aug;58(8):680-5.
Resolution of bronchial inflammation is related to bacterial eradication following treatment of exacerbations of chronic bronchitis.
White AJ, Gompertz S, Bayley DL, Hill SL, O'Brien C, Unsal I, Stockley RA.
Department of Respiratory Medicine, Queen Elizabeth Hospital, Birmingham B15 2TH, UK.
BACKGROUND: Recent studies of the role of bacteria in chronic bronchitis have shown that bacterial colonisation is associated with enhanced inflammation and that purulent acute exacerbations of chronic bronchitis (AECB) are associated with bacteria and characterised by increased inflammation. Changes in bronchial inflammation in response to the success or failure of bacterial eradication following AECB were therefore studied. METHODS: Bacterial quantitative culture and sputum markers of inflammation (myeloperoxidase (MPO), neutrophil elastase, leukotriene B4 (LTB4), sol:serum albumin ratio, and secretory leukoprotease inhibitor) were measured in patients presenting with culture positive purulent AECB and repeated 10 days and 2 months later. 41 patients provided sputum sufficient for both bacteriology and assessment of inflammation at baseline and day 10, and 46 provided sufficient sample for bacteriology, 40 of which could also be analysed for inflammation at 2 months (when clinically stable). RESULTS: At day 10, 17 of the 41 patient samples had a positive bacterial culture. In the stable state, 18 of the 46 samples had a positive culture, but with a significantly lower bacterial load than at presentation. Although there was no difference between the groups at presentation, the concentration of MPO was lower (p<0.05) in those in whom bacteria were eradicated by day 10 than in those with persisting bacteria. The LTB4 concentration was similarly lower (p<0.001) in those in whom bacteria were eradicated than in those with persistent bacteria. In the stable clinical state the concentrations of both MPO and LTB4 were lower in those in whom bacteria were eradicated than in patients with persisting bacteria. CONCLUSION: Resolution of bronchial inflammation following AECB is related to bacterial eradication. Those in whom bacteria continue to be cultured in their sputum have partial resolution of inflammation which may reflect continued stimulation by the reduced bacterial load.
online pharmacy ref. source: www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12885984&dopt=Abstract
An Sist Sanit Navar. 1999;22(1):81-5.
[The handling of inhalers by bronchitis patients]
[Article in Spanish]
Berrade E, Torrea S.
Hospital Virgen del Camino, 6 feminine planta, 31008 Pamplona, Spain.
A high percentage of patients are admitted to the Internal Medicine Unit with respiratory pathology, principally chronic obstructive pulmonary disease. The basis of treatment of the patient with chronic obstruction of the airways are the bronchodilators and corticoids administered by inhalation. There is a close relation between the correct use of the inhaler and its therapeutic efficiency. As chronic obstructive pulmonary disease is chronic, the patient is obliged to utilise inhaler treatment both in the hospital and at home. With the aim of determining what they know about inhalers, and how they use them, as well as to obtain information about the follow up practised with these patients, a study was designed that was carried out for one month in the Internal Medicine Unit of the "Virgen del Camino" Hospital of Pamplona. Data was gathered using a questionnaire with nine questions that were put to a sample of 23 patients admitted to this unit and who used inhalers during their hospital stay. It was verified that 57% of the patients did not use the inhalers correctly, 61% did not know when the container had run out and 70% did not even know the name of the medicine they were using. The study showed that the patients did not correctly administer the inhalatory medicines, which annulled or diminished the effectiveness of the treatment, given that there is a close relation between the correct use of the inhaler and its therapeutic efficiency.
online pharmacy ref. source: www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12886363&dopt=Abstract [PubMed - in process]
Zh Mikrobiol Epidemiol Immunobiol. 2003 Mar-Apr;(2):36-42.
[In Process Citation]
[Article in Russian]
[No authors listed]
Military Medical Academy, St. Petersburg, Russia.
Pneumococcal vaccine Pneumo-23, used for specific prophylaxis of pneumonia and other pneumococcal infections, was tested in military training units of the North Western, Central and Far Eastern Military Districts. The vaccine used for immunization of servicemen, was shown to have high immunogenicity with no adverse reactions. In the training group of the North Western Military District the epidemiological effectiveness of the vaccine was particularly high a month after immunization and amounted to 83.7%. During the period between month 2 and month 5 after immunization pneumonia morbidity among the immunized servicemen was 6.12 times lower than among the non-immunized ones. In the training units of the Central and Far Eastern Military Districts, where the period of the formation of postvaccinal immunity coincided with the peak of the outbreak of pneumonia, the protective properties of the used batches of the vaccine could be observed as early as during the first month after immunization, which made it possible to recommend this vaccine for urgent prophylaxis in the foci of pneumococcal infection. During the period of 5 months the effectiveness of the vaccine with respect to pneumonia was 62.1-66.2% for all three districts. The effectiveness of the combined immunization of conscripts with vaccines Pneumo-23 and Vaxigrip with respect to pneumonia was higher (78.54%) and the index of effectiveness (4.66) was 1.58 fold greater than in monoimmunization (2.95). The epidemiological effectiveness of the pneumococcal vaccine was high also with respect to other pneumococcal infections: acute bronchitis, acute respiratory diseases of pneumococcal etiology, cases of acute sinusitis and acute otitis. The use of the vaccine for the immunization of servicemen yielded the economic effect equal to 92 US dollars per person.
online pharmacy ref. source: www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12886605&dopt=Abstract [PubMed - in process]
Prescription drugs, surgical hair transplantation, topical application of various oils or creams... Also prayer and wishing...
Hair Million is an alternative approach to hair loss problems.
Anecdotes and personal experiences testify that it works. Hair Million shows positive results and improvement for age-related
hair thinning and hair loss for a large fraction of people who take it.
How does it work? Good question. The molecular biological or clinical mechanisms of action as to how Hair Million exactly works
to help stop hair loss, and promote hair growth is completely unknown.
The only evidences for the effecacy of Hair Million on hair growth are only anedotal and based on personal experiences.
There has been no clinical trials or placebo controlled statistical analysis on the efficacy of Hair Million on hair loss and hair growth.
That's enough for many people. Also, there are two merits in the hair restoration herbal formula:
Firstly, HairMillion is comparatively inexpensive, and secondly, it is made only of herbs
that are known to be safe when consumed in regular quantities. Herbs in Hair Million are also known for cardiotonic effects, meaning
that the herbs will make your heart stronger.
DreamPharm Online Healthy Supplements ||
Constipation relief, laxative, colon cleansing ||
Lutein ||
Progesterone Cream ||
Natural herbal formula for hair loss problems ||